Human IL-17AF (heterodimer) ELISA Ready-SET-Go!®

Also known as: Interleukin-IL-17AF, IL17AF

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 88-7117

Cat. No. Size
88-7117-22 2 x 96 tests w/plates
88-7117-86 10 x 96 tests w/plates
88-7117-88 10 x 96 tests
Please inquire about custom configurations or bulk packaging.

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Human IL-17AF (heterodimer) ELISA Ready-SET-Go!®.

Standard curve of Human IL-17AF (heterodimer) ELISA Ready-SET-Go!® ...View More

  • Data for Human IL-17AF (heterodimer) ELISA Ready-SET-Go!®.
Description

Description: This human IL-17AF ELISA Ready-SET-Go! Reagent set (with or without high-affinity binding microwell plates) contains the necessary reagents, buffers and diluents for performing quantitative enzyme-linked immunosorbent assays (ELISA). This ELISA reagent set is specifically engineered for accurate and precise measurement of human IL-17AF protein levels from serum, plasma and cell culture supernatants. This assay demonstrates parallelism in measuring recombinant and native human IL-17AF proteins and a standard curve range of 30 to 4000 pg/ml. Minimal crossreactivity to the IL-17A homodimer is observed (2%) and with no crossreactivity to IL-17F when spiked in excess (100ng/ml).

IL-17A and IL-17F are members of the IL-17 family and signature Th17 cytokines. Of the six IL-17 family members, IL-17F and IL-17A share the strongest homology (50% amino acid identity) and the two genes are located in the same chromosomal region. Although both IL-17A and IL-17F were originally found to be produced as disulfide-linked homodimers, recent studies have confirmed the production of IL-17AF heterodimers in in vitro-differentiated and polarized Th17 cells. Activated human CD4+ T cells in culture were found to secrete the IL-17F homodimer at 10-fold higher levels than the IL-17A homodimer, suggesting that the majority of the IL-17A protein expressed exists in the form of the IL-17AF heterodimer. Studies of Th17-polarized mouse splenocytes also indicate that the majority of IL-17 produced is complexed as the IL-17AF heterodimer. IL-17F and IL-17A have been observed in tissue samples from various autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, psoriasis, inflammatory bowel disease, and asthma.

Details
Reactivity Human
Sensitivity 30 pg/mL
Standard Curve Range 30-4000 pg/mL
Components Capture Antibody. Pre-titrated, purified antibody
Detection Antibody. Pre-titrated, biotin-conjugated antibody
Standard. Recombinant cytokine for generating standard curve and calibrating samples
Assay Diluent. 5X concentrated
Wash Buffer. 10X concentrated (100 ml of 10X per plate)
Detection enzyme. Pre-titrated Avidin-HRP
Substrate Solution. Tetramethylbenzidine (TMB) Substrate Solution
Stop Solution. 5 mls of 1X solution per plate
Certificate of Analysis. Lot-specific instructions for dilution of antibodies and standards
Reported Applications ELISA
Documentation
TDS Link Download TDS
Related Products
Cat. No. Name Excite Emit Application Reg.
13-7179 Anti-Human IL-17A Biotin ELISA RUO
14-7178 Anti-Human IL-17A Purified FC, ELISA, IHC, IP RUO
14-8178 Human IL-17AF Recombinant Protein ELISA, FA RUO
34-8178 Human IL-17AF Recombinant Protein Carrier-Free ELISA, FA RUO
88-7176 Human IL-17A (homodimer) ELISA Ready-SET-Go!® ELISA RUO
References

References: Chang SH, Dong C. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses. Cell Res. 2007 May;17(5):435-40.

Wright JF, Guo Y, Quazi A, Luxenberg DP, Bennett F, Ross JF, Qiu Y, Whitters MJ, Tomkinson KN, Dunussi-Joannopoulos K, Carreno BM, Collins M, Wolfman NM. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J Biol Chem. 2007 May 4;282(18):13447-55.

Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, Fouser LA. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006 Oct 2;203(10):2271-9.